Abstract: A friction material is made by molding and curing a composition containing a fibrous base that includes stainless steel fibers but not other steel fibers, a binder, and a friction modifier that includes at least two types of hard particles having a large Mohs hardness, bronze powder and a specific amount of tin sulfide. The friction material has a excellent balance of properties, including a high strain linearity that provides a excellent brake feel, a high torque linearity and a excellent effectiveness, and also minimizes disc rotor attack, disc pad wear and metal pickup. Such friction materials are particularly suitable for automotive applications, such as disc pads.

Abstract: A solvent system for an ink including a nitro solvent; an ink further including a film-forming resin, a pigment or dye, and, optionally, a substrate wetting agent; and a marking instrument containing the ink, are disclosed.

Abstract: An ink composition useful in an oil-based ballpoint pen capable of drawing a satisfactory line on the surfaces of various materials to be written which are not only papers but also non-permeable materials such as glasses and plastics as well as fibrous materials such as fabrics is provided. Such a ink composition comprises a colorant, an organic solvent having a vapor pressure of 5.0 to 50 mmHg (20° C.) as a main solvent, such as n-propyl alcohol, isopropyl alcohol and propylene glycol monomethyl ether and a shear-viscosity reducing agent.

Abstract: A cured coating for a siliceous material, preferably an optical fiber, comprises a thermally cured polyorganosilsesquioxane having an oxide powder dispersed therein. The oxide powder has a refractive index from about 1.2 to about 2.7 and includes particles having a particle size less than about 100 nanometers. The cured coating has adhesion to the siliceous material and is transparent to ultraviolet radiation.

Abstract: The invention has for its primary object to provide a solid composition having excellent wet-surface writing properties and high safety. The object is accomplished by the provision of a solid composition characterized by its comprising a colorant, a gelation agent, a resin component and at least two kinds of solvents, each of the resins having the following attribute a) or b): a) the solvent has an HLB value (X) of X?6.5 or b) the solvent has an HLB value (X) and a solubility parameter value (Y) satisfying the relation of Y?18?X (on condition that 6.5<X, 0<Y).

Abstract: Aqueous dispersions of water-soluble polymers of N-vinylcarboxamides contain, based on 100 parts of water, (A) from 5 to 80 parts by weight of water-soluble polymer containing N-vinylformamide units and/or N-vinylacetamide units and having particle sizes of from 50 nm to 2 ?m and (B) from 1 to 50 parts by weight of at least one polymeric dispersant which is incompatible with the water-soluble polymers (A) in aqueous solution, which dispersions are prepared by polymerizing (A) from 5 to 80 parts by weight of N-vinylformamide and/or N-vinylacetamide, if desired together with other monoethylenically unsaturated monomers which form water-soluble polymers therewith, and (B) from 1 to 50 parts by weight of at least one polymeric dispersant which is incompatible with the polymers, formed from the monomers (A), in aqueous solution, in 100 parts by weight of water, at from 30 to 95° C. in the presence of from 0.001 to 5.

Abstract: The present invention describes a process for preparing a synergistic stabilizer mixture comprising the components of the general formulae (I), (II) and (III) in accordance with claim 1, characterized by the reaction of compounds of the formula (V) with an epihalohydrin of the formula (VI) in the presence of a phase transfer catalyst and from 4 to 20 times the molar amount of an alkali metal hydroxide, relative to compound (V), at from 20 to 220° C. Removal of the excess epihalohydrin and phase separation are followed by polymerization at from 100 to 240° C.

Abstract: This invention relates to polycarbonate compositions comprising: (A) at least one polycarbonate comprising repeating units derived from a dihydroxyaromatic compound or a dihydroxyaliphatic compound of the formula HO—Y—OH; and (B) at least one salt prepared from the reaction of one or more acidic phosphorus-containing compounds and one or more hindered amine light stabilizers. The polycarbonate compositions exhibit improved hydrolytic stability.

Abstract: Disclosed are polymer blends comprising polycarbonate(s) and polyester(s) wherein the polycarbonate is a polycarbonate derived from bisphenol A and the polyester comprises residues of or is derived from one or more aromatic dicarboxylic acids, neopentyl glycol, and 1,4-cyclohexanedimethanol.

Abstract: A process for producing plasticized polyamide blends containing additives such as tougheners, reinforcing agents, and/or filler. High average molecular weight plasticized blends containing additives may be made using the process of the invention. Pipes and tubing may be made from the blends prepared using the process of the invention.

Abstract: Esters of cyclohexane polycarboxylic acids are used as plasticisers for polyvinyl chloride to enable products with comparable mechanical properties to be obtained using less polyvinyl chloride. Use of these esters also produces formulations with increased stability to ultra-violet light, improved low temperature properties, lower viscosity and improved processability as well as reduced smoke on burning. The esters of cyclohexane polycarboxylic acids may be used alone or in admixture with other plasticisers when the esters of cyclohexane polycarboxylic acids may act as viscosity depressants. Fast fusing plasticisers may also be included. The formulations are particularly useful in the production of a range of goods from semi-rigid to highly flexible materials and are particularly useful in the production of medical materials such as blood bags and tubing.

Abstract: This invention relates to a polymer precursor dispersion for use in making a polymer that is a solid at room temperature and further relates to a method of making same where the dispersion comprises a polymer precursor comprising an addition monomer, a condensation monomer, a prepolymer, or a polymer modifier and 0.01 to 50 weight percent of a micropulp having a volume average length of from 0.01 to 100 micrometers.

Abstract: Disclosed is a process of forming a prepreg material having substantially no voids. According to the process of the invention, the reinforcing material is heated to a temperature above the temperature of the impregnating resin. The prepreg formed has substantially no voids and does not require lengthy consolidation when formed into useful articles.

Abstract: The present invention relates to pressure sensitive adhesive compositions prepared from novel anionic block copolymers of aromatic vinyl compounds and conjugated dienes. The block copolymers are a mixture of a high molecular weight linear and/or radial block copolymer component (SBC1 and/or SBC2), and a diblock copolymer component (D1). The block copolymer may be combined with other block copolymers, tackifying resins, oils and other components to form the adhesives of the present invention. The pressure sensitive adhesives of the present invention maintain their performance at elevated temperatures and fail cohesively making them particularly useful for die-cuttable label applications. The pressure sensitive adhesives compositions may also comprise ester plasticizers typically used for PVC and thus make adhesives particularly suitable for PVC film labels and decals.

Abstract: An aqueous thermosetting primer composition includes a polyurethane polymer, an acrylic polymer polymerized in a wax having crosslinkable functionality, and a crosslinking component that is reactive with the wax and at least one of the polyurethane polymer and the acrylic polymer. The polyurethane polymer has a glass transition temperature of 0° C. or less. The acrylic polymer has a glass transition temperature that is at least about 20° C. higher than the glass transition temperature of polyurethane resin. The invention further provides a composite coating having as a primer layer a cured layer of the primer composition of the invention and having at least one topcoat layer.

Abstract: The object of the present invention is to significantly improve weather resistance over a long period of time of the cured product of the invention, while maintaining physical properties, such as tensile properties and rubber-like elasticity, at levels required of sealing compositions for use in general buildings. The curable composition of the invention is a curable composition which comprises a vinyl polymer having a reactive silicon containing group (a), such as a (meth) acrylic polymer having a reactive silicon containing group, a polyoxyalkylene polymer having a reactive silicon containing group (b), such as a polyoxypropylene having a reactive silicon containing group, and a plasticizer having an acrylic component (c), such as an acrylic polymer, and is reacted and crosslinked in the presence of moisture to provide a rubbery cured product.

Abstract: A process for preparing fluoropolymer dispersions, substantially free from anionic fluorinated surfactants, and with a coagulum amount <0.1% by weight, comprising: a) step a1) addition of: a non ionic surfactant having cloud point (CP) between 40° and 80° C., in an amount from 1.5% to 50% by weight on the dispersion fluoropolymer; and optionally an electrolyte to bring the specific conductivity of the dispersion to values in the range 130-8,000 ?S/cm; optionally a buffer agent to have a pH between 2 and 12 to a fluoropolymer dispersion obtainable by an emulsion polymerization process; step a2): heating of the dispersion obtained in a1) up to a temperature Tc in the range CP±10° C.; decantation without stirring, at the temperature Tc, until obtaining the dispersion separation in two aqueous phases, of which the lower one containing the fluoropolymer is discharged; b) step b1): the dispersion obtained in step a2) is optionally additioned of an electrolyte and of a non ionic surfactant as in a1).

Abstract: A curable composition and a method of rendering a base material or a shaped item antifouling comprising coating or impregnating a surface of the base material with the curable composition comprising (A) an organopolysiloxane having functional groups capable of condensation reaction at both molecular terminals thereof and (B) a hydrophobic silica wherein the hydrophobic silica (B) is thermally treated together with the organipolysiloxane (A).

Abstract: A hardener composition for use as a component of a two component polyurethane coating composition, comprising a polyisocyanate, a catalyst for promoting reaction of the polyisocyanate with a reactive hydrogen compound, and one or more antioxidants selected from: a first antioxidant comprising one or more of sterically hindered phenol antioxidants and secondary aryl amine antioxidants, and a second antioxidant comprising one or more organophosphite antioxidant, exhibits improved color stability.

Abstract: Olefin polymerization processes using catalyst systems based on metallocenes and olefin, in particular, propylene polymers obtainable thereby. The metallocenes may be represented by the formula: wherein M1 preferably is zirconium or hafnium; and R12 is different from hydrogen.

Abstract: The invention is directed to a direct to metal coating composition containing an acrylic polyol synthesized with a phosphated monomer having improved adhesion and corrosion resistance characteristics. The invention is also directed to a method for producing a direct to metal coating composition containing an acrylic polyol synthesized with a phosphated monomer on a substrate by applying the coating composition of the invention to a metal surface. The invention is further directed to an acrylic polyol synthesized with a phosphated monomer coated article having improved adhesion and corrosion resistance characteristics.

Abstract: Compositions comprising a reaction product of a) an asymmetrical, saturated polyisocyanate that is non-cyclic, non-aromatic, and has at least 3 carbon atoms in the polyisocyanate per isocyanate group, b) a material that is at least one of i) a primary carbamate material having at least one functional group reactive with an isocyanate and at least one primary carbamate group or a group convertible to a primary carbamate group and ii) a reaction product of the primary carbamate material and an extending agent, and c) optionally, a chain extension agent that has at least difunctional reactivity with an isocyanate. Also, methods of making these compositions.

Abstract: A clear paint for golf balls includes essentially a base polymer including a polyurethane resin, and a graft polymer including a comb polymer having a backbone portion formed of an acrylic resin and a branch portion formed of polyorganosiloxane. The backbone portion of the comb polymer has at least one hydroxyl group.

Abstract: The invention relates to photochromic monomers based on benzothiophenes and a method for preparing them, and to photochromic polymers-polyazomethines that are reversibly photocontrollable due to the introduction of photochromic fragments from the class of dihetarylethenes into their structure. The invention provides photochromic photocontrollable polymers for the creation of new information technologies.

Abstract: The invention concerns a method for preparing polyisocyanates by cyclodimerization of isocyanate functions borne by initial monomer isocyanates. The invention is characterised in that it comprises steps which consist in: a) providing a reaction medium comprising initial monomer isocyanates, optionally in the presence of a solvent; b) adding to said reaction mixture a (cyclo)dimerization catalyst comprising a compound of the family of super acids; c) heating the reaction medium to a temperature ranging between 0° C. and 300° C., advantageously between 20° C. and 200° C. until the desired rate of transformation is obtained; d) optionally inactivating or eliminating the reaction catalyst; and e) optionally eliminating the unreacted monomer.

Abstract: A method for reducing the permeation rate of a permeable species through a polymeric material includes identifying a solubility-increasing species in the polymeric material having a reversible affinity for the permeable species, and removing or altering at least a portion of the solubility-increasing species in the polymeric material. In one application, the permeable species is water, and the solubility-increasing species is hygroscopic. A example of a polymeric material is an elastomeric polymer. The solubility-increasing species may be removed in part from an existing piece of the polymeric material by leaching it out. The polymeric material may instead be manufactured with a reduced content of the solubility-increasing species.

Abstract: A method for preparing an aromatic chloroformate comprising, introducing a mixture of at least one aromatic hydroxyl compound, phosgene, at least one solvent, and at least one organic base into a flow reactor to obtain a unidirectionally flowing reaction mixture. The unidirectionally flowing reaction mixture is maintained at a temperature between about 0° C. and about 60° C. to produce a single product stream comprising an aromatic chloroformate.

Abstract: Disclosed are oriented, shaped articles such as, for example, film, fibers, bottles, and tubes, with excellent strength, toughness, clarity, chemical resistance, and UV resistance. The articles can be prepared from cycloaliphatic polyesters and from compositions comprising cycloaliphatic polyesters and cycloaliphatic polyester elastomers. The articles may be oriented by stretching in at least one direction and have a modulus which results in a soft feel. Also disclosed are polyester compositions comprising cycloaliphatic polyesters and polyester elastomers.

Abstract: Polyamide hot-melt adhesives based on the reaction products of polymeric fatty acids, C14-C18 monocarboxylic acids, C6-C12 dicarboxylic acids and diamines which do not contain any water-extractable, environmentally toxic constituents, which are suitable for sealing cavities in soils, in rock formations, building structures and/or walls, in particular for sealing tunnels, galleries, shafts, channels or caverns, to protect against the penetration of water or the penetration of liquids or gases which contain hazardous substances.

Abstract: The present invention relates to a resin surface treating agent containing as an effective component at least one cerium compound selected from tetravalent and trivalent cerium compounds. The surface treating method of the present invention is a method of bringing a surface of a resin into contact with a surface treating agent containing as an effective component at least one cerium compound selected from tetravalent and trivalent cerium compounds, and thereafter treating the surface with an acidic aqueous solution. This activates the resin surface and thereby increases a strength of adhesion of, for instance, a polyimide-based resin film with metal wires, as well as a strength of adhesion of a polyimide-based resin film with another resin. Thus, a resin surface treating agent that provides excellent productivity and reduces processing costs, as well as a surface treating method using the same, are provided.

Abstract: This invention relates to a method of extending the shelf-life of constructs, in particular bioabsorbable stents, comprising semi-crystalline polymers by increasing the crystallinity of the polymers.

Abstract: The present application discloses a transfection effective carrier polypeptide comprising derivatives of HIV Tat peptide.

Abstract: The present invention relates to a novel polypeptide (BCMP 101) compositions comprising the polypeptide, including vaccines, and antibodies that are immunospecific for the polypeptide. The use of the polypeptide in the diagnosis, prophylaxis and treatment of cancer, in particular breast cancer is also provided.

Abstract: Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that affect satiety. The methods are useful for treating conditions or disorders, including obesity, Type II diabetes, eating disorders, and insulin-resistance syndrome. The methods are also useful for lowering the plasma glucose level, lowering the plasma lipid level, reducing the cardiac risk, reducing the appetite, and reducing the weight of subjects. Pharmaceutical compositions for use in the methods of the invention are also disclosed.

Abstract: The present invention provides a protein scaffold, such as an avian pancreatic polypeptide, that can be modified by substitution of two or more amino acid residues that are exposed on the alpha helix domain of the polypeptide when the polypeptide is in a tertiary form.

Abstract: Crystalline IGF-1 is provided along with a method for production thereof. Crystallizing IGF-1 comprises the steps of mixing an aqueous solution comprising IGF-1 with a reservoir solution comprising a precipitant to form a mixture; and crystallizing the mixture, optionally also recrystallizing and isolating the crystalline IGF-1. In addition, a method for identifying IGF-1 indirect agonists is provided using a detergent as a standard for the level of inhibition of binding of IGFBP-1 or IGFBP-3 to IGF-1 and/or using the coordinates of the binding pockets of IGF-1 to which a candidate indirect agonist binds for structure-based drug design.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods, for producing the polypeptides of the present invention.

Abstract: The present invention concerns novel polypeptides having opioid receptor activity, the genetic material permitting their expression, recombinant cells expressing these polypeptides, and their use.

Abstract: Isolated or biologically pure taste receptors comprised of at least one T1R2 and T1R3 polypeptide and compositions containing are provided. These taste receptors specifically bind and/or are specifically activated by sweet taste stimuli such as natural and artificial sweetener compounds. These taste receptors are useful in screening assays for identifying compounds that elicit or modulate (enhance or inhibit) sweet taste. These compounds can be used as additives and flavorants to improve the taste of compositions for human or animal consumption. In preferred embodiments, the T1R2/T1R3 receptor will be comprised of human T1R2/human T1R3 expressed in association with a suitable G protein, preferably Gaa15.

Abstract: The present invention enabled the detection and quantification of CAST, which is localized to synapses and tightly bound to the cytomatrix, and of the mRNA encoding the CAST. Furthermore, it was revealed that CAST functions as a protein scaffold for localizing RIM1 to synapses, contributing as a molecular basis for active zone formation.

Abstract: The present invention concerns the use of inhibitors for the treatment and/or prophylaxis of diseases which are the consequence of increased receptor tyrosine kinase activity, particularly cancer. The use is particularly directed towards inhibition or lowering of the overexpression and/or altered activity of receptor tyrosine kinases (RTKs). In particular, this altered activity of receptor tyrosine kinase can be triggered by a mutation of FGFR-4, wherein this mutation is in particular a point mutation in the transmembrane domain of FGFR-4 and leads to an exchange of a hydrophobic amino acid for a hydrophilic amino acid. The invention further concerns the use of an inhibitor directed against FGFR-4, for the treatment and/or prophylaxis of cancer. Furthermore, the invention concerns a mutated FGFR-4, which leads to overexpression and/or altered activity in cells. Finally, the invention concerns a DNA and RNA sequence of a mutated FGFR-4 molecule.

Abstract: A variant of a polypeptide comprising a human IgG Fc region is described, which variant comprises an amino acid substitution at one or more of amino acid positions 270, 322, 326, 327, 329, 331, 333 or 334 of the human IgG Fc region. Such variants display altered effector function. For example, C1q binding and/or complement dependent cytotoxicity (CDC) activity may be altered in the variant polypeptide. The application also discloses a variant of a parent polypeptide comprising a human IgG Fc region, which variant has a better binding affinity for human C1q than the parent polypeptide.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: A process for the purification of recombinant human Chorionic Gonadotropin (hCG) from a sample of crude recombinant hCG in the supernatant of CHO cells comprises the combined use of ion-exchange chromatography and reverse phase HPLC. The ion-exchange chromatography is performed twice and the final use of a size exclusion chromatography allows the purification from any residual traces of contaminants. The specific bioactivity of the highly purified hCG obtained form the process is particularly high, amounting to about 25,000 IU/mg.